Zafin Kansa

Zafin Kansa
Description (en)
Iri	pain (en) Alamun Cutar Daji
Sanadi	Sankara, Chemotherapy, hormone therapy (en) targeted therapy (en)
Identifier (en)
MeSH	D000072716

Ciwo a cikin ciwon daji na iya tasowa daga matsewar ƙwayar cuta ko shiga sassan jikin da ke kusa; daga jiyya da hanyoyin bincike; ko daga fata, jijiya da sauran canje-canjen da ke haifar da rashin daidaituwa na hormone ko amsawar rigakafi. Yawancin ciwo na yau da kullum (dadewa) yana haifar da rashin lafiya kuma mafi yawan ciwo mai tsanani (na gajeren lokaci) yana haifar da magani ko hanyoyin bincike. Koyaya, aikin rediyo, tiyata da chemotherapy na iya haifar da yanayi mai raɗaɗi wanda ke daɗe bayan an gama jiyya.

Kasancewar jin zafi ya dogara ne akan wurin da ciwon daji yake da kuma matakin cutar.^[1] A kowane lokaci, kusan rabin mutanen da aka gano suna da mummunar cutar kansa suna fama da ciwo, kuma kashi biyu cikin uku na wadanda ke fama da ciwon daji suna fama da zafi na irin wannan tsanani wanda ya yi mummunar tasiri ga barci, yanayi, zamantakewar zamantakewa da kuma ayyukan rayuwar yau da kullum.^[1][2][3]

Tare da ingantaccen kulawa, ana iya kawar da ciwon daji ko kuma sarrafa shi sosai a cikin 80% zuwa 90% na lokuta, amma kusan 50% na masu fama da ciwon daji a cikin ƙasashen da suka ci gaba suna samun ƙasa da kulawa mafi kyau. A duk duniya, kusan kashi 80 cikin 100 na mutanen da ke fama da ciwon daji suna samun ɗan magani kaɗan ko babu.^[4] Ciwon daji a cikin yara da kuma mutanen da ke da nakasar hankali kuma an ba da rahoton cewa ba a yi musu magani ba.^[5]

Hukumar Lafiya ta Duniya (WHO) da sauran su ne suka buga ka'idojin amfani da kwayoyi wajen kula da ciwon daji. ^{[6] [7]} Ma'aikatan kiwon lafiya suna da haƙƙin ɗabi'a don tabbatar da cewa, duk lokacin da zai yiwu, majiyyaci ko mai kula da majiyyaci suna da masaniya game da haɗari da fa'idodin da ke tattare da zaɓuɓɓukan sarrafa ciwo . Ingantacciyar kulawar jin zafi na iya ɗan ɗan rage rayuwar mutum da ke mutuwa.^[8]

1. ↑ ^{1.0 1.1} Hanna M, Zylicz Z, eds. (1 January 2013). Cancer Pain. Springer. pp. vii & 17. ISBN 978-0-85729-230-8.
2. ↑ Marcus DA (August 2011). "Epidemiology of cancer pain". Current Pain and Headache Reports. 15 (4): 231–4. doi:10.1007/s11916-011-0208-0. PMID 21556709. S2CID 11459509.
3. ↑ Sheinfeld Gorin S, Krebs P, Badr H, Janke EA, Jim HS, Spring B, et al. (February 2012). "Meta-analysis of psychosocial interventions to reduce pain in patients with cancer". Journal of Clinical Oncology. 30 (5): 539–47. doi:10.1200/JCO.2011.37.0437. PMC 6815997. PMID 22253460.
4. ↑ Hanna M, Zylicz Z (2013). "Introduction". In Hanna M, Zylicz Z (eds.). Cancer pain. Springer. p. 1. ISBN 9780857292308. LCCN 2013945729.
5. ↑ Millard, Samantha K.; de Knegt, Nanda C. (December 2019). "Cancer Pain in People With Intellectual Disabilities: Systematic Review and Survey of Health Care Professionals". Journal of Pain and Symptom Management. 58 (6): 1081–1099.e3. doi:10.1016/j.jpainsymman.2019.07.013. ISSN 0885-3924. PMID 31326504.
6. ↑ WHO guidelines:
7. ↑ Other clinical guidelines:
8. ↑ Randall F (2008). "Ethical issues in cancer pain management". In Sykes N, Bennett MI, Yuan CS (eds.). Clinical pain management: Cancer pain (2nd ed.). London: Hodder Arnold. pp. 93–100. ISBN 978-0-340-94007-5.